Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PIMT Inhibitors

PIMT Inhibitors refer to a class of chemical compounds designed to specifically target and modulate the activity of the enzyme Protein L-Isoaspartyl Methyltransferase (PIMT). PIMT is a critical enzyme involved in the repair of damaged proteins, particularly those containing abnormal isoaspartyl residues. These isoaspartyl residues can arise from spontaneous protein deamidation or damage due to chemical and physical stress. PIMT catalyzes the conversion of these abnormal isoaspartyl residues back into their normal forms, thus preserving the structural and functional integrity of proteins. PIMT inhibitors, as the name suggests, are compounds that interfere with the enzymatic activity of PIMT, potentially leading to the accumulation of damaged proteins within cells.

The mechanism of action of PIMT inhibitors typically involves binding to the active site of the PIMT enzyme or disrupting its essential cofactors or coenzymes. By inhibiting PIMT, these compounds inhibit the enzyme from efficiently repairing isoaspartyl residues in proteins, which can have downstream consequences on cellular function. The development of PIMT inhibitors is of interest in the field of molecular biology and protein chemistry, as they can serve as valuable tools for studying the consequences of isoaspartyl residue accumulation in various cellular processes. Additionally, understanding the role of PIMT and its regulation through inhibitors may offer insights into the mechanisms underlying protein misfolding and the development of age-related diseases like neurodegenerative disorders. These inhibitors hold significant promise in advancing our understanding of protein homeostasis and the broader implications of protein damage within biological systems.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Inhibits the BCR-ABL kinase, blocking cell signaling in chronic myeloid leukemia.

Ritonavir

155213-67-5sc-208310
10 mg
$124.00
7
(1)

Acts as a protease inhibitor, preventing viral replication in HIV-infected cells.

Tamoxifen

10540-29-1sc-208414
2.5 g
$272.00
18
(2)

Competes with estrogen for binding to estrogen receptors.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Targets the EGFR kinase, disrupting signaling pathways in non-small cell lung cancer.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Inhibits multiple kinases, including RAF and VEGFR.

Omeprazole

73590-58-6sc-202265
50 mg
$67.00
4
(1)

Proton pump inhibitor that reduces gastric acid production, used for acid-related disorders.

Rosiglitazone

122320-73-4sc-202795
sc-202795A
sc-202795C
sc-202795D
sc-202795B
25 mg
100 mg
500 mg
1 g
5 g
$120.00
$326.00
$634.00
$947.00
$1259.00
38
(1)

Activates PPARγ.

Allopurinol

315-30-0sc-207272
25 g
$131.00
(0)

Blocks xanthine oxidase to reduce uric acid production.

Cimetidine

51481-61-9sc-202996
sc-202996A
5 g
10 g
$62.00
$86.00
1
(1)

Histamine H2 receptor antagonist, decreasing gastric acid secretion for ulcers and GERD.

Donepezil

120014-06-4sc-279006
10 mg
$74.00
3
(1)

Acetylcholinesterase inhibitor.